Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial
PaperCitations, authors & open-access status
Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 153 citations, 2017 year and bronze oa status.
153
Citations
2017
Year
bronze
OA Status